PAMELA LOPEZ: Open Payments
NPI 1952474397 · WESLACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,670 in 141 payments from 24 companies in 2025. Trend: 2023 $4,372 · 2024 $4,821 · 2025 $4,670
Food & beverage: $4,670
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $552 |
| Abbott Laboratories | 11 | $532 |
| Lilly USA, LLC | 17 | $483 |
| Corcept Therapeutics | 22 | $476 |
| Dexcom, Inc. | 8 | $395 |
| Ascensia Diabetes Care Us Inc. | 10 | $329 |
| Madrigal Pharmaceuticals | 4 | $293 |
| Amgen Inc. | 13 | $252 |
| Boston Scientific Corporation | 3 | $177 |
| Radius Health, Inc. | 7 | $163 |
Products named: Korlym, FREESTYLE LIBRE, Ozempic, REZDIFFRA, Dexcom G6 Transmitter, Wegovy, Tymlos, MOUNJARO.
Industry payments across TX — which companies pay providers there.
